Dual role of endogenous nitric oxide in tumor necrosis factor shock: Induced NO tempers oxidative stress

Cellular and Molecular Life Sciences

Volumn 62, Issue 14, 2005, Pages 1632-1640

  Cauwels, A ^a   Bultinck, J ^a   Brouckaert, P ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Mice; Nitric oxide; Oxidative stress; TNF shock

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE A2 INHIBITOR; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME INHIBITION; FEMALE; HEMODYNAMICS; IN VIVO STUDY; KIDNEY; LIPID PEROXIDATION; LIVER; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SHOCK;

ALDEHYDES; ANIMALS; ANTIOXIDANTS; BUTYLATED HYDROXYANISOLE; CATALASE; CYCLIC N-OXIDES; ENZYME INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PHOSPHOLIPASES A; REACTIVE OXYGEN SPECIES; SHOCK; SPIN LABELS; SUPEROXIDE DISMUTASE; SURVIVAL RATE; TUMOR NECROSIS FACTORS;

EID: 22544449597     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-5142-z     Document Type: Article

References (53)

1. Vassalli P. (1992) The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411-452
2. Aggarwal B. B. (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756
3. Wang X., Li X., Erhardt J. A., Barone F. C. and Feuerstein G. Z. (2000) Detection of tumor necrosis factor-alpha mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction. J. Cereb. Blood. Flow Metab. 20: 15-20
4. Kurrelmeyer K. M., Michael L. H., Baumgarten G., Taffet G. E., Peschon J. J., Sivasubramanian N. et al. (2000) Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc. Natl. Acad. Sci. USA 97: 5456-5461
5. Teoh N., Field J., Sutton J. and Farrell G. (2004) Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatology 39: 412-421
6. Alexander R. B. and Rosenberg S. A. (1991) Tumor necrosis factor: Clinical applications. In: Biologic Therapy of Cancer, pp. 378-392, DeVita V. T., Hellman S. and Rosenberg S. A. (eds), Lippincott, Philadelphia
7. Cobb J. P., Natanson C., Hoffman W. D., Lodato R. F., Banks S., Koev C. A. et al. (1992) N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J. Exp. Med. 176: 1175-1182
8. Geroulanos S., Schilling J., Cakmakci M., Jung H. H. and Largiader F. (1992) Inhibition of NO synthesis in septic shock. Lancet 339: 435
9. Kilbourn R. G., Gross S. S., Jubran A., Adams J., Griffith O. W., Levi R. et al. (1990) NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87: 3629-2632
10. Thiemermann C. and Vane J. (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182: 591-595
11. Avontuur J. A., Tutein Nolthenius R. P., Bodegom J. W. van and Bruining H. A. (1998) Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit. Care Med. 26: 660-667
12. Lopez A., Lorente J. A., Steingrub J., Bakker J., McLuckie A., Willatts S. et al. (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med. 32: 21-30
13. Hock C. E., Yin K., Yue G. and Wong P. Y. (1997) Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 272: H843-H850
14. Wray G. M., Millar C. G., Hinds C. J. and Thiemermann C. (1998) Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 9: 329-335
15. Gundersen Y., Corso C. O., Leiderer R., Dörger M., Lilleaasen P., Aasen A. O. et al. (1997) Use of selective and nonselective nitric oxide synthase inhibitors in rat endotoxemia: effects on hepatic morphology and function. Shock 8: 368-372
16. Thiemermann C., Ruetten H., Wu C. C. and Vane J. R. (1995) The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br. J. Pharmacol. 116: 2845-2851
17. Cauwels A., Van Molle W., Janssen B., Everaerdt B., Huang P., Fiers W. et al. (2000) Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase. Immunity 13: 223-231
18. Thannickal V. J. and Fanburg B. L. (2000) Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L1005-L1028
19. Li J. M. and Shah A. M. (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287: R1014-R1030
20. Huie R. E. and Padmaja S. (1993) The reaction of NO with superoxide. Free Radic. Res. Commun. 18: 195-199
21. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S. et al. (1994) Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269: 26066-26075
22. Miles A. M., Bohle D. S., Glassbrenner P. A., Hansert B., Wink D. A. and Grisham M. B. (1996) Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem. 271: 40-47
23. Rubbo H., Radi R., Anselmi D., Kirk M., Barnes S., Butler J. et al. (2000) Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation: greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate. J. Biol. Chem. 275: 10812-10818
24. Kubes P., Kanwar S., Niu X. F. and Gaboury J. P. (1993) Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7: 1293-1299
25. Hickey M. J., Granger D. N. and Kubes P. (2001) Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/ endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol. Scand. 173: 119-126
26. Clancy R. M., Leszczynska-Piziak J. and Abramson S. B. (1992) Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90: 1116-1121
27. Frank S., Zacharowski K., Wray G. M., Thiemermann C. and Pfeilschifter J. (1999) Identification of copper/zinc superoxide dismutase as a novel nitric oxide-regulated gene in rat glomerular mesangial cells and kidneys of endotoxemic rats. FASEB J. 13: 869-882
28. Coffey M. J., Coles B. and O'Donnell V. B. (2001) Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases. Free Radic. Res. 35: 447-464
29. Pollock J. D., Williams D. A., Gifford M. A., Li L. L., Du X., Fisherman J. et al. (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9: 202-209
30. Laubach V. E., Shesely E. G., Smithies O. and Sherman P. A. (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92: 10688-10692
31. Shesely E. G., Maeda N., Kim H. S., Desai K. M., Krege J. H., Laubach V. E. et al. (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93: 13176-13181
32. Esterbauer H., Schaur R. J. and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11: 81-128
33. Zarkovic N. (2003) 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol. Aspects Med. 24: 281-291
34. Cuzzocrea S., Thiemermann C. and Salvemini D. (2004) Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr. Med. Chem. 11: 1147-1162
35. Zöllner S., Haseloff R. F., Kirilyuk I. A., Blasig I. E. and Rubanyi G. M. (1997) Nitroxides increase the detectable amount of nitric oxide released from endothelial cells. J. Biol. Chem. 272: 23076-23080
36. Schnackenberg C. G., Welch W. J. and Wilcox C. S. (1998) Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32: 59-64
37. Santos N. C., Figueira-Coelho J., Martins-Silva J. and Saldanha C. (2003) Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem. Pharmacol. 65: 1035-1041
38. Schulze-Osthoff K., Bakker A. C., Vanhaesebroeck B., Beyaert R., Jacob W. A. and Fiers W. (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267: 5317-5323
39. Li Y. and Trush M. A. (1998) Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun. 253: 295-299
40. Rosenthal M. D., Vishwanath B. S. and Franson R. C. (1989) Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils. Biochim. Biophys. Acta 1001: 1-8
41. Denson D. D., Wang X., Worrell R. T., Al Khalili O. and Eaton D. C. (2001) Cytosolic phospholipase A2 is required for optimal ATP activation of BK channels in GH(3) cells. J. Biol. Chem. 276: 7136-7142
42. Uozumi N., Kume K., Nagase T., Nakatani N., Ishii S., Tashiro F. et al. (1997) Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390: 618-622
43. Cauwels A., Janssen B., Waeytens A., Cuvelier C. and Brouckaert P. (2003) Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4: 387-393
44. Fones E., Amigo H., Gallegos K., Guerrero A. and Ferreira J. (1989) t-Butyl-4-hydroxyanisole as an inhibitor of tumor cell respiration. Biochem. Pharmacol. 38: 3443-3451
45. Ferreira J. (1990) Effect of butylated hydroxyanisole on electron transport in rat liver mitochondria. Biochem. Pharmacol. 40: 677-684
46. Brekke O. L., Sagen E. and Bjerve K. S. (1999) Specificity of endogenous fatty acid release during tumor necrosis factor-induced apoptosis in WEHI 164 fibrosarcoma cells. J. Lipid Res. 40: 2223-2233
47. Xia Y. and Zweier J. L. (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. USA 94: 6954-6958
48. Giulivi C., Poderoso J. J. and Boveris A. (1998) Production of nitric oxide by mitochondria. J. Biol. Chem. 273: 11038-11043
49. Cosentino F. and Katusic Z. S. (1995) Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91: 139-144
50. Vasquez-Vivar J., Kalyanaraman B. and Martasek P. (2003) The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic. Res. 37: 121-127
51. Uchida K. (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 42: 318-343
52. Hattori Y., Hattori S. and Kasai K. (2001) 4-Hydroxynonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappaB-dependent transcriptional activation of inducible NO synthase. Arterioscler. Thromb. Vasc. Biol. 21: 1179-1183
53. Liu W., Kato M., Itoigawa M., Murakami H., Yajima M., Wu J. et al. (2001) Distinct involvement of NF-kappaB and p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal. J. Cell. Biochem. 83: 271-280